commit | 108f1171c18387f80596e8709c7b7552c47fe457 | [log] [tgz] |
---|---|---|
author | Fabian Meumertzheim <fabian@meumertzhe.im> | Thu Sep 26 12:30:47 2024 -0700 |
committer | Copybara-Service <copybara-worker@google.com> | Thu Sep 26 12:32:17 2024 -0700 |
tree | 9415b66e32c2bcfb53bc206ad6b0b2503d1a8a3a | |
parent | 3699636eaaaa6024bf9f71ab889cbe7818d02c09 [diff] |
Make `launcher_maker` cross-platform `//tools/launcher:launcher_maker` produces launchers *for* Windows, but there is no reason why it must *run on* Windows. By making it runnable on all platforms, `*_binary` targets can be built *for* Windows from any platform assuming that a suitable cross-compiling C++ toolchain is available. Closes #23731. PiperOrigin-RevId: 679251350 Change-Id: I1b380d5b28a616ace88a3b049a2b4554aa209ae3
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md